Prostate Adenocarcinoma with Neuroendocrine Differentiation
📧 Sign up to get email alerts when something new happens for Prostate Adenocarcinoma with Neuroendocrine Differentiation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC) [Phase 2]
Phase 2 clinical trial evaluating Sacituzumab Tirumotecan in combination with Tagitanlimab for aggressive variant and neuroendocrine prostat…